Beijing DIAGREAT Biotechnology Co., Ltd
Founded in 2013, Beijing DIAGREAT Biotechnology Co., Ltd. is headquartered in the Beijing Economic-Technological Development Area. Its team comprises senior experts and PhDs in clinical medicine, pharmacy, immunology and clinical laboratory medicine with profound experience in precision medicine.
As a globally leading enterprise in AI-assisted precision drug therapy, DIAGREAT leverages artificial intelligence to enable scientific decision-making for complex drug therapies, providing reliable solutions for clinical personalized precision medication, safety monitoring and rapid evaluation of new drugs.
Focusing on the precision medicine sector, the company has developed application models for precision drug therapy based on large models, realizing precise drug treatment through intelligent applications from genetic testing to therapeutic drug monitoring.
DIAGREAT specializes in innovative technologies and product research for Therapeutic Drug Monitoring (TDM), also known as blood drug concentration monitoring.
Guided by pharmacokinetic theories, TDM uses sensitive and reliable analytical techniques to measure drug concentrations in blood, analyze the correlation between drug concentration, efficacy and toxicity, and further design or adjust dosage regimens to achieve precision therapy.
DIAGREAT has innovatively realized the intelligent, automated and point-of-care implementation of therapeutic drug concentration determination and TDM.
The company owns an upstream core raw material R&D and production platform for TDM, covering small molecule site-specific conjugation, antibody R&D and production, protein engineering, enzyme engineering, nucleic acid synthesis and modification, primer-probe synthesis, gene synthesis and sequencing, achieving full independence in upstream core raw materials and technologies. It has been granted 51 patents worldwide, including 39 Chinese invention patents, 6 invention patents in the US and Europe, and 12 design and utility model patents.
DIAGREAT possesses more than 200 medical device registration certificates with globally exclusive or internationally leading technologies, as well as over 180 certifications including EU CE and Brazil certifications. It has passed ISO 9001 and ISO 13485 international quality management system certifications. Its core products are exported to more than 60 countries and regions, and serve hundreds of Class III Grade A hospitals across China.